Patents by Inventor David M. Foureau

David M. Foureau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10656144
    Abstract: The present invention provides methods for determining the level or status of minimal residue disease (MRD) in a multiple myeloma (MM) patient including analyzing peripheral natural killer (NK), NK-T and T cell distribution and/or activation, and quantifying inflammatory cytokines, chemokines and growth factors in a biological sample obtained from an MM patient to provide a peripheral immune profile; and obtaining a level or status of MRD in the MM patient from the peripheral immune profile, wherein if the peripheral immune profile exceeds a pre-determined threshold, the MM patient is positive for MRD.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: May 19, 2020
    Assignee: The Charlotte Mecklenburg Hospital Authority
    Inventors: Saad Z. Usmani, Manisha Bhutani, Qing Zhang, David M. Foureau
  • Publication number: 20180156784
    Abstract: The present invention provides methods for determining the level or status of minimal residue disease (MRD) in a multiple myeloma (MM) patient including analyzing peripheral NK, NK-T and T cell distribution and/or activation, and quantifying inflammatory cytokines, chemokines and growth factors in a biological sample obtained from an MM patient to provide a peripheral immune profile; and obtaining a level or status of MRD in the MM patient from the peripheral immune profile, wherein if the peripheral immune profile exceeds a pre-determined threshold, the MM patient is positive for MRD.
    Type: Application
    Filed: December 1, 2017
    Publication date: June 7, 2018
    Inventors: Saad Z. Usmani, Manisha Bhutani, Qing Zhang, David M. Foureau
  • Patent number: 9289381
    Abstract: The present invention relates to compositions and methods for the preparation, stabilization, and/or storage of active agents, particularly therapeutic proteins and polypeptides such as Interleukin-2.
    Type: Grant
    Filed: December 3, 2010
    Date of Patent: March 22, 2016
    Assignees: The University of North Carolina at Charlotte, The Charlotte-Mecklenburg Hospital Authority, Monash University
    Inventors: Gloria Elliott, Douglas MacFarlane, David M. Foureau, Iain McKillop
  • Publication number: 20120230944
    Abstract: The present invention relates to compositions and methods for the preparation, stabilization, and/or storage of active agents, particularly therapeutic proteins and polypeptides such as Interleukin-2.
    Type: Application
    Filed: December 3, 2010
    Publication date: September 13, 2012
    Inventors: Gloria Elliott, Douglas MacFarlane, David M. Foureau, Iain McKillop